XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
INO Inovio Pharmaceuticals
- 2.1500
- +0.0200+0.94%
Close Feb 14 16:00 ET
- 2.1400
- -0.0100-0.47%
Post 20:01 ET
77.61MMarket Cap-0.49P/E (TTM)
2.2400High2.1200Low993.53KVolume2.1500Open2.1300Pre Close2.16MTurnover2.78%Turnover RatioLossP/E (Static)36.10MShares14.748052wk High1.06P/B76.72MFloat Cap1.740052wk Low--Dividend TTM35.68MShs Float2352.0000Historical High--Div YieldTTM5.63%Amplitude1.7400Historical Low2.1780Avg Price1Lot Size
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025
Inovio Pharmaceuticals Stock Forum
Breakthrough RRP Treatment Slashes Surgery Need: 28% of Patients Now Surgery-Free in Nature Communications Study
INOVIO Announces Phase 1/2 Trial Results Of INO-3107 For Recurrent Respiratory Papillomatosis With 81% Of Patients Requiring Fewer Surgeries; Plans BLA Submission In Mid-2025 For FDA Accelerated Approval, Aiming To Achieve First US DNA Medicine Approval
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, ...
Complete Response Data: INOVIO's INO-3107 Shows HPV Elimination in RRP Patients
Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference
Monday, 10th February at 8:05 am
Poster will describe loss of detectable HPV-6 in Recurrent Respiratory Papillomatosis patients following treatment with INO-3107
PLYMOUTH MEETING, Pa., Feb. 10, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to...
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release
7. Remember, some stocks may get pumped WITHOUT any catalyst
8. NEVER be a blind follower.
LASTLY, If y...
$Aethlon Medical (AEMD.US)$
$BioCryst Pharmaceuticals (BCRX.US)$
$CureVac (CVAC.US)$
$GeoVax Labs (GOVX.US)$
$Inovio Pharmaceuticals (INO.US)$
$Nanoviricides (NNVC.US)$
$China SXT Pharmaceuticals (SXTC.US)$
$Virax Biolabs (VRAX.US)$
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours)
7. Remember, ...
No comment yet